Top Stories for the Week of March 5th 2007

Tuesday, March 6, 2007 12:57 PM

Top News

PPD Signs Risk-Sharing Deal with Indian Generics Company Ranbaxy

Wilmington, N.C.-based contract research organization (CRO) PPD has licensed investigational statin RBx-10558 from India-based generics company Ranbaxy Laboratories, which recently began developing novel drugs.

inVentiv Health Makes Two More Acquisitions and Reports Strong Revenues

Somerset, N.J.-based inVentiv Health, a life science communications company with a contract research organization (CRO) unit, reported a nearly 40% jump in revenues to $766.2 million in 2006. For its fourth quarter, inVentiv reported revenues jumped 21% to $211.8 million.

Other breaking news...      

  • PRA fourth quarter revenues jump...
  • RapidTrials launches web-based CME program...

Company Profile: An interview with Jules Mitchel, managing director, ACTN, and president Target Health, Asian Clinical Trial Network (ACTN)

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs